Under the condition without H2O2-stimulation, pretreatment with SB203580, SP600125 or U0126, significantly decreased the expression of IL-33 in HBECs from COPD patients (Fig. 5c-e). Here, IL33 is linked to chronic obstructive pulmonary disease.